TDOC
Teladoc Health, Inc.
6.10$
+0.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 28.2% | 29.3% | 30.1% | 29.3% | 28.1% | 29.5% | 31.3% | 30.2% | 29.9% | 30.7% | 47.2% | -2.5% | 26.5% | |
| 71.8% | 70.7% | 69.9% | 70.7% | 71.9% | 70.5% | 68.7% | 69.8% | 70.1% | 69.3% | 52.8% | 102.5% | 73.5% | |
| 16.2% | 4.7% | 12.6% | 16.7% | 16.9% | 3.2% | 11.1% | 17.9% | 10.8% | 11.1% | 11.1% | 10.4% | 10.8% | |
| 17.5% | 16.5% | 17.3% | 17.1% | 17.8% | 15.6% | 17.9% | 17.1% | 16.4% | 16.9% | 16.6% | 17.1% | 16.8% | |
| 81.6% | 76.0% | 83.4% | 201.7% | 78.9% | 78.0% | 87.9% | 78.5% | 78.4% | 74.9% | 60.7% | 108.6% | 80.5% | |
| -9.8% | -5.3% | -13.5% | -130.9% | -6.9% | -7.5% | -19.2% | -8.6% | -8.3% | -5.6% | -7.9% | -6.1% | -7.0% | |
| 0.9% | 0.8% | 0.9% | 0.9% | 0.9% | 1.1% | 0.9% | 0.7% | 0.7% | 0.8% | 0.9% | 0.8% | 0.8% | |
| -9.0% | -3.8% | -12.3% | -129.8% | -5.1% | -7.5% | -17.7% | -6.4% | -8.0% | -5.2% | -9.9% | -6.2% | -7.3% | |
| -0.4% | 0.5% | 0.4% | 0.6% | 0.1% | 0.0% | -2.9% | -1.2% | -0.1% | -1.3% | 0.5% | 0.2% | -0.2% | |
| -8.6% | -4.4% | -12.7% | -130.4% | -5.2% | -7.6% | -14.8% | -5.2% | -7.9% | -3.9% | -10.4% | -6.4% | -7.1% | |
| 2.0% | 6.6% | -1.6% | 2.6% | 2.1% | 1.8% | -1.4% | 0.4% | -5.6% | 8.0% | 6.3% | -20.5% | -2.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.